BCEL
Price
$0.15
Change
-$0.00 (-0.00%)
Updated
Mar 18 closing price
78 days until earnings call
NKTX
Price
$6.53
Change
-$0.20 (-2.97%)
Updated
May 21 closing price
79 days until earnings call
Ad is loading...

BCEL vs NKTX

Header iconBCEL vs NKTX Comparison
Open Charts BCEL vs NKTXBanner chart's image
Atreca
Price$0.15
Change-$0.00 (-0.00%)
Volume$334.25K
CapitalizationN/A
Nkarta
Price$6.53
Change-$0.20 (-2.97%)
Volume$198.54K
CapitalizationN/A
View a ticker or compare two or three
BCEL vs NKTX Comparison Chart

Loading...

BCELDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NKTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCEL vs. NKTX commentary
May 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCEL is a StrongBuy and NKTX is a Hold.

COMPARISON
Comparison
May 21, 2024
Stock price -- (BCEL: $0.09 vs. NKTX: $6.53)
Brand notoriety: BCEL and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCEL: 11% vs. NKTX: 44%
Market capitalization -- BCEL: $3.65M vs. NKTX: $460.15M
BCEL [@Biotechnology] is valued at $3.65M. NKTX’s [@Biotechnology] market capitalization is $460.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCEL’s FA Score shows that 0 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • BCEL’s FA Score: 0 green, 5 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, NKTX is a better buy in the long-term than BCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCEL’s TA Score shows that 3 TA indicator(s) are bullish while NKTX’s TA Score has 5 bullish TA indicator(s).

  • BCEL’s TA Score: 3 bullish, 3 bearish.
  • NKTX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NKTX is a better buy in the short-term than BCEL.

Price Growth

BCEL (@Biotechnology) experienced а +2.11% price change this week, while NKTX (@Biotechnology) price change was +4.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.66%. For the same industry, the average monthly price growth was +6.20%, and the average quarterly price growth was +62.92%.

Reported Earning Dates

BCEL is expected to report earnings on Aug 07, 2024.

NKTX is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (+1.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCEL with price predictions.
OPEN
A.I.dvisor published
a Summary for NKTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NKTX($460M) has a higher market cap than BCEL($3.65M). NKTX YTD gains are higher at: -1.061 vs. BCEL (-30.303).
BCELNKTXBCEL / NKTX
Capitalization3.65M460M1%
EBITDAN/AN/A-
Gain YTD-30.303-1.0612,857%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
BCELNKTX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 20 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BCELDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NKTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENVX10.040.85
+9.25%
Enovix Corp
KBH73.050.28
+0.38%
KB Home
GROW2.680.01
+0.37%
US Global Investors
EPD28.56-0.05
-0.17%
Enterprise Products Partners LP
UHG5.76-0.25
-4.16%
United Homes Group

BCEL and

Correlation & Price change

A.I.dvisor tells us that BCEL and RVNC have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BCEL and RVNC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCEL
1D Price
Change %
BCEL100%
+2.11%
RVNC - BCEL
30%
Poorly correlated
-4.43%
KZR - BCEL
29%
Poorly correlated
-0.30%
NKTX - BCEL
28%
Poorly correlated
-4.25%
ZVRA - BCEL
27%
Poorly correlated
-0.63%
OCX - BCEL
27%
Poorly correlated
-4.56%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been closely correlated with NTBL. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if NKTX jumps, then NTBL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-4.25%
NTBL - NKTX
67%
Closely correlated
-1.92%
ICCC - NKTX
43%
Loosely correlated
+0.21%
ASMB - NKTX
41%
Loosely correlated
-1.29%
FATE - NKTX
40%
Loosely correlated
-5.80%
ERAS - NKTX
34%
Loosely correlated
+6.49%
More